Deutsche Bank Ag\ Landos Biopharma, Inc. Transaction History

Deutsche Bank Ag\

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$0.6 - $1.5 $23,530 - $58,825	39,217 Added 1542.15%	41,760 $30,000
Q1 2022 May 13, 2022	SELL	$1.44 - $5.22 $432 - $1,566	-300 Reduced 10.55%	2,543 $4,000
Q4 2021 Feb 11, 2022	BUY	$4.7 - $15.0 $705 - $2,250	150 Added 5.57%	2,843 $14,000
Q3 2021 Nov 04, 2021	SELL	$9.77 - $15.77 $11,294 - $18,230	-1,156 Reduced 30.03%	2,693 $39,000
Q2 2021 Aug 11, 2021	SELL	$9.26 - $12.53 $1,166 - $1,578	-126 Reduced 3.17%	3,849 $44,000
Q1 2021 May 13, 2021	BUY	$9.47 - $16.26 $37,643 - $64,633	3,975 New	3,975 $38,000

Ticker LABP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,254,900
Description
Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of u...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.